Biotech Holdings Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Holdings

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: jacq who wrote (68)	5/14/1997 12:42:00 PM
From: Mike Heimbuch	of 224

Jacq - thank you for the reply These clinical trials of DIAB II in China - have produced what can only be termed outstanding results (80% retained patients. This information has not been substantiated outside the compay - to my knowledge. I have received private e-mail and feedback from others in the Diabetes treatment community - who of prudent scepticism - can only wonder why such a successful testing followed by government acceptance and sales - wasn't noted in some common internation forum or publication. It seems there are 2 general categories of why this situation exists. 1. The company has a time-line and philosophy for patent protection, technology development and marketing - and they are following it. 2. There is either fraud or gross and negligent error in the claims. I have clients - for whom investing in such a forward looking company - is often little more than a matter of trust in the individuals who speak for the company. We don't have alot of choices when it comes to that issue - you either do or don't. I have come to place my trust in these folks - but!!! - - Biotech Holdings could make tremendous use of even one - independant - publicly disclosed - peer review or test result verification. Mike up North

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next